Eli C Lewis
Overview
Explore the profile of Eli C Lewis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
2241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Schuster R, Motola-Kalay N, Baranovski B, Bar L, Tov N, Stein M, et al.
Cell Immunol
. 2020 Aug;
356:104177.
PMID: 32795666
Alpha1-antitrypsin (AAT) is a serum protease inhibitor that rises during inflammation and healthy pregnancies. Plasma-derived AAT, indicated for genetic AAT deficiency, is presently being explored for additional medical indications. Unlike...
12.
Lior Y, Jasevitch M, Ochayon D, Zaretsky M, Lewis E, Aharoni A
Cell Immunol
. 2020 Jul;
355:104135.
PMID: 32703529
Primarily known as an elastase inhibitor, human alpha1-antitrypsin also exerts anti-inflammatory and immunomodulatory effects, both in vitro and in vivo. While the anti-protease mechanism of alpha1-antitrypsin is attributed to a...
13.
Endogenous α1-antitrypsin levels in the perilymphatic fluid correlates with severity of hearing loss
El-Saied S, Schmitt H, Durisin M, Joshua B, Tailakh M, Prenzler N, et al.
Clin Otolaryngol
. 2020 Apr;
45(4):495-499.
PMID: 32246580
Objectives: To determine the levels of endogenous α1-antitrypsin in the perilymph of patients undergoing cochlear implant (CI), and its reverse association with the severity of hearing loss. Study Design: Retrospective...
14.
Cerqueira F, Kozer N, Petcherski A, Baranovski B, Wolf D, Assali E, et al.
Biochem J
. 2020 Feb;
477(2):461-475.
PMID: 32003437
Mitochondrial turnover is required for proper cellular function. Both mitochondrial biogenesis and mitophagy are impaired in several degenerative and age-related diseases. The search for mitophagy activators recently emerged as a...
15.
Brami I, Ini D, Sassonker N, Zaknoun M, Zuckerman T, Lewis E
Biol Blood Marrow Transplant
. 2020 Jan;
26(4):625-633.
PMID: 31899361
Immunosuppressive drugs are an inherent component of hematopoietic stem cell transplantation (HSCT) for the prevention of acute graft-versus-host disease (GVHD). Circulating α1-antitrypsin (AAT), a serine-protease inhibitor produced predominantly by hepatocytes...
16.
Lebenthal Y, Brener A, Hershkovitz E, Shehadeh N, Shalitin S, Lewis E, et al.
Int J Mol Sci
. 2019 Dec;
20(23).
PMID: 31795482
Our aim was to assess the efficacy, safety, and tolerability of alpha-1 antitrypsin (AAT) as a therapeutic modality for β-cell preservation in patients with recent-onset type 1 diabetes. Seventy type...
17.
Schuster R, Bar-Nathan O, Tiosano A, Lewis E, Silberstein E
Adv Wound Care (New Rochelle)
. 2019 Nov;
8(7):281-290.
PMID: 31737418
Skin flaps are routinely used in reconstructive surgery yet remain susceptible to ischemia and necrosis. Distant flaps require lengthy time to detach causing patient discomfort. Human α1-antitrypsin (hAAT) is a...
18.
Tal Y, Ribak Y, Khalaila A, Shamriz O, Marcus N, Zinger A, et al.
Clin Immunol
. 2019 Aug;
212:108249.
PMID: 31445170
Genetic aberrations in the toll-like receptor (TLR)3 pathway are associated with increased susceptibility to herpes simplex virus (HSV) infections. Leucine-rich repeat and PYD-containing protein (NLRP)12 is a component of the...
19.
Kaner Z, Engelman R, Schuster R, Rider P, Greenberg D, Av-Gay Y, et al.
Front Immunol
. 2019 Apr;
10:590.
PMID: 31001247
Human α1-antitrypsin (hAAT) is a circulating anti-inflammatory serine-protease inhibitor that rises during acute phase responses. , hAAT reduces bacterial load, without directly inhibiting bacterial growth. In conditions of excess nitric-oxide...
20.
Baranovski B, Schuster R, Nisim O, Brami I, Lior Y, Lewis E
Chronic Obstr Pulm Dis
. 2019 Feb;
5(4):267-276.
PMID: 30723784
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder which most commonly manifests as pulmonary emphysema. Accordingly, alpha-1 antitrypsin (AAT) augmentation therapy aims to reduce the progression of emphysema, as achieved...